tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Brandon Folkes, 118 are a BUY (84.89%), 1 are a SELL (0.72%), 20 are a HOLD (14.39%).
Analyst Brandon Folkes, currently employed at CIBC, carries an average stock price target met ratio of 33.06% that have a potential upside of 20.96% achieved within 186 days.
Brandon Folkes’s has documented 274 price targets and ratings displayed on 36 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MNKD, MannKind Corp at 17-Sep-2025.
Analyst best performing recommendations are on MNTA (MOMENTA PHARMACEUTICALS).
The best stock recommendation documented was for OMER (OMEROS) at 11/14/2024. The price target of $9 was fulfilled within 8 days with a profit of $2.05 (29.5%) receiving and performance score of 36.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$6
$0.41 (7.33%)
$8
3 years 7 months 17 days ago
(25-Feb-2022)
1/4 (25%)
$2.17 (44.83%)
281
Hold
$5
$-0.59 (-10.55%)
3 years 7 months 29 days ago
(13-Feb-2022)
0/1 (0%)
$-0.56 (-10.07%)
Hold
$4.5
$-1.09 (-19.50%)
3 years 8 months 22 days ago
(20-Jan-2022)
4/4 (100%)
$1.14 (33.93%)
167
Buy
$6.25
$0.66 (11.81%)
$5
4 years 5 months 7 days ago
(06-May-2021)
1/2 (50%)
$3.07 (96.54%)
287
Buy
$8
$2.41 (43.11%)
5 years 10 months 29 days ago
(13-Nov-2019)
1/2 (50%)
$2.26 (36.00%)
1683
Which stock is Brandon Folkes is most bullish on?
Which stock is Brandon Folkes is most reserved on?
What Year was the first public recommendation made by Brandon Folkes?
